Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
20%

OVERLAP
BY WEIGHT
22

# OF OVERLAPPING
HOLDINGS
PBE
33
HOLDINGS
76%
ALSO IN XBI
XBI
137
HOLDINGS
16%
ALSO IN PBE
SECTOR DRIFT (PBE minus XBI)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in XBI
Overlap
HALOZYME THERAPEUTICS INC 2.6% 1.5% 1.5%
PROTAGONIST THERAPEUTICS, INC. 3.0% 1.4% 1.4%
REGENERON PHARMACEUTICALS 4.7% 1.3% 1.3%
VERTEX PHARMACEUTICALS INC 5.0% 1.1% 1.1%
GILEAD SCIENCES INC 4.5% 1.1% 1.1%
PBE Overweight Relative to XBI
ROYALTY PHARMA PLC CLASS A 4.8%
VERTEX PHARMACEUTICALS INC 3.9%
BIOGEN IDEC INC 3.9%
AMGEN INC 3.8%
ALNYLAM PHARMACEUTICALS INC 3.7%
UNITED THERAPEUTICS CORP 3.6%
REGENERON PHARMACEUTICALS 3.4%
GILEAD SCIENCES INC 3.4%
BIO-TECHNE CORPORATION 3.2%
REPLIGEN CORP 3.0%
PBE Underweight Relative to XBI
MODERNA, INC. -3.0%
TWIST BIOSCIENCE CORP. -1.8%
NATERA INC -1.5%
KYMERA THERAPEUTICS, INC. -1.4%
ORUKA THERAPEUTICS INC -1.4%
ROIVANT SCIENCES LTD. -1.4%
TRAVERE THERAPEUTICS, INC. -1.4%
REVOLUTION MEDICINES, INC. -1.4%
INSMED INC -1.4%
DIANTHUS THERAPEUTICS INC -1.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY